SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-18-007940
Filing Date
2018-07-23
Accepted
2018-07-23 17:05:29
Documents
4
Period of Report
2018-08-27
Effectiveness Date
2018-07-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A azrxdef14a_aug132018.htm DEF 14A 435296
2 IMAGE azrx.jpg GRAPHIC 5312
3 IMAGE azrxdef14a_aug132018000.jpg GRAPHIC 2841
4 IMAGE proxycard000.jpg GRAPHIC 92869
  Complete submission text file 0001654954-18-007940.txt   575972
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 18965026
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1